Zhejiang Hisoar Pharmaceutical's net cash position indicates...
Zhejiang Hisoar Pharmaceutical's net cash position indicates manageable debt, but its revenue shrinkage and EBIT loss over the last year are worrisome. Despite positive free cash flow, lack of revenue growth and positive EBIT are areas of concern.
Is Zhejiang Hisoar Pharmaceutical (SZSE:002099) A Risky Investment?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment